H. Douglas

发表

Selective protection against conidia by mononuclear and against mycelia by polymorphonuclear phagocytes in resistance to Aspergillus. Observations on these two lines of defense in vivo and in vitro with human and mouse phagocytes.

A. Schaffner, A. Braude, H. Douglas, 1982, The Journal of clinical investigation.

Identification and localization of cyst-specific antigens of Giardia lamblia

D. S. Reiner, F. Gillin, H. Douglas, 1989, Infection and immunity.

Passive immunization against the local Shwartzman reaction.

A. Braude, H. Douglas, Herndon Douglas, 1972, Journal of immunology.

Analysis of sugars in bacterial endotoxins by gas-liquid chromatography.

S. Freedman, A. Braude, C. Davis, 1969, Analytical biochemistry.

Treatment and prevention of intravascular coagulation with antiserum to endotoxin.

A. Braude, C. Davis, H. Douglas, 1973, The Journal of infectious diseases.

Killing of Aspergillus spores depends on the anatomical source of the macrophage

A. Schaffner, A. Braude, C. Davis, 1983, Infection and immunity.

Protection against gram-negative bacteremia and endotoxemia with human monoclonal IgM antibodies.

H. Kaplan, N. Teng, A. Braude, 1985, Proceedings of the National Academy of Sciences of the United States of America.

Induction of immunity against lethal Haemophilus influenzae type b infection by Escherichia coli core lipopolysaccharide.

E. Ziegler, L. Corbeil, M. Marks, 1982, The Journal of clinical investigation.

Lethal Haemophilus influenzae type b infection in mice

E. Ziegler, L. Corbeil, M. Marks, 1982, Infection.

RELATIONSHIP BETWEEN PARTICLE SIZE AND BIOLOGICAL ACTIVITY OF E. COLI BOIVIN ENDOTOXIN.

T. Staehelin, A. Braude, H. Douglas, 1965, The Journal of clinical investigation.

Fever from pathogenic fungi.

J. Mcconnell, A. Braude, H. Douglas, 1960, The Journal of clinical investigation.

Treatment of E. coli and klebsiella bacteremia in agranulocytic animals with antiserum to a UDP-gal epimerase-deficient mutant.

E. Ziegler, A. Braude, H. Douglas, 1973, Journal of immunology.

Prevention of lethal pseudomonas bacteremia with epimerase-deficient E. coli antiserum.

J. McCutchan, E. Ziegler, A. Braude, 1975, Transactions of the Association of American Physicians.

Prevention of death from endotoxin with antisera. I. The risk of fatal anaphylaxis to endotoxin.

K. R. Brown, A. Braude, H. Douglas, 1969, Journal of immunology.

In vitro susceptibility of fungi to killing by neutrophil granulocytes discriminates between primary pathogenicity and opportunism.

A. Schaffner, T. Schaffner, A. Braude, 1986, The Journal of clinical investigation.

Treatment of gram-negative bacteremia and shock with human antiserum to a mutant Escherichia coli.

J. Fierer, E. Ziegler, A. Braude, 1982, The New England journal of medicine.

TREATMENT OF GRAM-NEGATIVE BACTEREMIA AND SHOCK WITH HUMAN ANTISERUM TO A MUTANT ESCHERICHIA COLI

J. McCutchan, J. Fierer, J. Sadoff, 1983 .

Antibody to cell wall glycolipid of Gram-negative bacteria: induction of immunity to bacteremia and endotoxemia.

J. McCutchan, E. Ziegler, A. Braude, 1977, Journal of Infectious Diseases.

Models of T cell deficiency in listeriosis: the effects of cortisone and cyclosporin A on normal and nude BALB/c mice.

A. Schaffner, H. Douglas, C. E. Davis, 1983, Journal of Immunology.

Pseudomonas aeruginosa vasculitis and bacteremia following conjunctivitis: a simple model of fatal pseudomonas infection in neutropenia.

E. Ziegler, H. Douglas, 1979, The Journal of infectious diseases.

Fibrin-Enmeshed Tobramycin Liposomes: Single Application Topical Therapy of Pseudomonas Keratitis

R. Weinreb, S. I. Brown, D. Schanzlin, 1992, Cornea.

PROTECTION AGAINST LETHALITY OF E. COLI ENDOTOXIN WITH “O” ANTISERUM *

W. W. Wells, A. Braude, H. Douglas, 1966, Annals of the New York Academy of Sciences.

Prevention of death from endotoxin with antisera. II. Elimination of the risk of anaphylaxis to endotoxin.

K. R. Brown, A. Braude, H. Douglas, 1971, Journal of immunology.

Immunization against nosocomial infection.

J. McCutchan, E. Ziegler, A. Braude, 1981, The American journal of medicine.

Human antiserum for prevention of the local shwartzman reaction and death from bacterial lipopolysaccharides.

E. Ziegler, A. Braude, H. Douglas, 1973, The Journal of clinical investigation.

Successful treatment of human gram-negative bacteremia with antiserum against endotoxin core.

J. McCutchan, E. Ziegler, A. Braude, 1981, Transactions of the Association of American Physicians.

Experimental Production of Lethal Escherichia coli Bacteremia of Pelvic Origin

A. Braude, H. Douglas, J. Jones, 1969, Journal of bacteriology.

The behavior of Escherichia coli endotoxin (somatic antigen) during infectious arthritis.

A. Braude, H. Douglas, J. Jones, 1963, Journal of immunology.

Experimental bacteremia due to Pseudomonas in agranulocytic animals.

E. Ziegler, A. Braude, H. Douglas, 1974, The Journal of infectious diseases.

Encystation and expression of cyst antigens by Giardia lamblia in vitro.

D. S. Reiner, F. Gillin, H. Douglas, 1987, Science.

A new method for purification of Giardia lamblia cysts.

D. S. Reiner, F. Gillin, H. Douglas, 1987, Transactions of the Royal Society of Tropical Medicine and Hygiene.

Growth and antigenic variation of Trypanosoma brucei, T. rhodesiense and T. gambiense in subcutaneous millipore chambers.

C. Davis, H. Douglas, D. Goddard, 1985, Transactions of the Royal Society of Tropical Medicine and Hygiene.

Characterization of specific binding of a human immunoglobulin M monoclonal antibody to lipopolysaccharide and its lipid A domain

R. Dellinger, G. Knatterud, Y. Fujihara, 1993, Infection and immunity.